The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Next Generation Sequencing (NGS) Market Research Report 2025

Global Next Generation Sequencing (NGS) Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1889101

No of Pages : 109

Ask Your Query
Synopsis
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
The global Next Generation Sequencing (NGS) market was valued at US$ 3690.2 million in 2023 and is anticipated to reach US$ 4686.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing (NGS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing (NGS).
Report Scope
The Next Generation Sequencing (NGS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Sequencing (NGS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Sequencing (NGS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
Roche
Agilent Technologies
Perkinelmer
Genomatix
PierianDx
Eurofins Scientific
Gatc Biotech
Oxford Nanopore Technologies
Bio-Rad Laboratories
DNASTAR
Biomatters
Partek
New England Biolabs
Myriad Genetics
Macrogen
Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Segment by Application
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Sequencing (NGS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 Market by Application
1.3.1 Global Next Generation Sequencing (NGS) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic & Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing (NGS) Market Perspective (2019-2030)
2.2 Next Generation Sequencing (NGS) Growth Trends by Region
2.2.1 Global Next Generation Sequencing (NGS) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next Generation Sequencing (NGS) Historic Market Size by Region (2019-2024)
2.2.3 Next Generation Sequencing (NGS) Forecasted Market Size by Region (2025-2030)
2.3 Next Generation Sequencing (NGS) Market Dynamics
2.3.1 Next Generation Sequencing (NGS) Industry Trends
2.3.2 Next Generation Sequencing (NGS) Market Drivers
2.3.3 Next Generation Sequencing (NGS) Market Challenges
2.3.4 Next Generation Sequencing (NGS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing (NGS) Players by Revenue
3.1.1 Global Top Next Generation Sequencing (NGS) Players by Revenue (2019-2024)
3.1.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Players (2019-2024)
3.2 Global Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing (NGS) Revenue
3.4 Global Next Generation Sequencing (NGS) Market Concentration Ratio
3.4.1 Global Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Revenue in 2023
3.5 Next Generation Sequencing (NGS) Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing (NGS) Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing (NGS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing (NGS) Breakdown Data by Type
4.1 Global Next Generation Sequencing (NGS) Historic Market Size by Type (2019-2024)
4.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2025-2030)
5 Next Generation Sequencing (NGS) Breakdown Data by Application
5.1 Global Next Generation Sequencing (NGS) Historic Market Size by Application (2019-2024)
5.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Next Generation Sequencing (NGS) Market Size (2019-2030)
6.2 North America Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next Generation Sequencing (NGS) Market Size by Country (2019-2024)
6.4 North America Next Generation Sequencing (NGS) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Sequencing (NGS) Market Size (2019-2030)
7.2 Europe Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next Generation Sequencing (NGS) Market Size by Country (2019-2024)
7.4 Europe Next Generation Sequencing (NGS) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size (2019-2030)
8.2 Asia-Pacific Next Generation Sequencing (NGS) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2019-2024)
8.4 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Sequencing (NGS) Market Size (2019-2030)
9.2 Latin America Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next Generation Sequencing (NGS) Market Size by Country (2019-2024)
9.4 Latin America Next Generation Sequencing (NGS) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size (2019-2030)
10.2 Middle East & Africa Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2019-2024)
10.4 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Next Generation Sequencing (NGS) Introduction
11.1.4 Illumina Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Pacific Biosciences of California
11.3.1 Pacific Biosciences of California Company Detail
11.3.2 Pacific Biosciences of California Business Overview
11.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Introduction
11.3.4 Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.3.5 Pacific Biosciences of California Recent Development
11.4 Beijing Genomics Institute
11.4.1 Beijing Genomics Institute Company Detail
11.4.2 Beijing Genomics Institute Business Overview
11.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Introduction
11.4.4 Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.4.5 Beijing Genomics Institute Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Next Generation Sequencing (NGS) Introduction
11.5.4 Qiagen Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.5.5 Qiagen Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Next Generation Sequencing (NGS) Introduction
11.6.4 Roche Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Detail
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Next Generation Sequencing (NGS) Introduction
11.7.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.7.5 Agilent Technologies Recent Development
11.8 Perkinelmer
11.8.1 Perkinelmer Company Detail
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer Next Generation Sequencing (NGS) Introduction
11.8.4 Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.8.5 Perkinelmer Recent Development
11.9 Genomatix
11.9.1 Genomatix Company Detail
11.9.2 Genomatix Business Overview
11.9.3 Genomatix Next Generation Sequencing (NGS) Introduction
11.9.4 Genomatix Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.9.5 Genomatix Recent Development
11.10 PierianDx
11.10.1 PierianDx Company Detail
11.10.2 PierianDx Business Overview
11.10.3 PierianDx Next Generation Sequencing (NGS) Introduction
11.10.4 PierianDx Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.10.5 PierianDx Recent Development
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Detail
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Introduction
11.11.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.11.5 Eurofins Scientific Recent Development
11.12 Gatc Biotech
11.12.1 Gatc Biotech Company Detail
11.12.2 Gatc Biotech Business Overview
11.12.3 Gatc Biotech Next Generation Sequencing (NGS) Introduction
11.12.4 Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.12.5 Gatc Biotech Recent Development
11.13 Oxford Nanopore Technologies
11.13.1 Oxford Nanopore Technologies Company Detail
11.13.2 Oxford Nanopore Technologies Business Overview
11.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Introduction
11.13.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.13.5 Oxford Nanopore Technologies Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Detail
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Introduction
11.14.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 DNASTAR
11.15.1 DNASTAR Company Detail
11.15.2 DNASTAR Business Overview
11.15.3 DNASTAR Next Generation Sequencing (NGS) Introduction
11.15.4 DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.15.5 DNASTAR Recent Development
11.16 Biomatters
11.16.1 Biomatters Company Detail
11.16.2 Biomatters Business Overview
11.16.3 Biomatters Next Generation Sequencing (NGS) Introduction
11.16.4 Biomatters Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.16.5 Biomatters Recent Development
11.17 Partek
11.17.1 Partek Company Detail
11.17.2 Partek Business Overview
11.17.3 Partek Next Generation Sequencing (NGS) Introduction
11.17.4 Partek Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.17.5 Partek Recent Development
11.18 New England Biolabs
11.18.1 New England Biolabs Company Detail
11.18.2 New England Biolabs Business Overview
11.18.3 New England Biolabs Next Generation Sequencing (NGS) Introduction
11.18.4 New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.18.5 New England Biolabs Recent Development
11.19 Myriad Genetics
11.19.1 Myriad Genetics Company Detail
11.19.2 Myriad Genetics Business Overview
11.19.3 Myriad Genetics Next Generation Sequencing (NGS) Introduction
11.19.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.19.5 Myriad Genetics Recent Development
11.20 Macrogen
11.20.1 Macrogen Company Detail
11.20.2 Macrogen Business Overview
11.20.3 Macrogen Next Generation Sequencing (NGS) Introduction
11.20.4 Macrogen Revenue in Next Generation Sequencing (NGS) Business (2019-2024)
11.20.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock